Menu
Recruiting NCT05768841

Prevalence of Mental Health Issues in Endurance Athletes.

Observational Depression, Anxiety Mental Health Issue

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: mental health issues.
Who it may be relevant to
Registry conditions: Depression, Anxiety, Mental Health Issue. Basic parameters: from 16 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Participation in endurance sports has been increasing over the last few decades and our aim of our exploratory descriptive survey study is therefore to examine mental health issues in endurance athletes (marathon runners, ultra endurance runners, triathletes), employing the IOC assessment tool, to provide information on mental health issues in this population. Secondary objects are to evaluate risk factors for mental health issues in endurance athletes (like exercise behaviour, competition behaviour, age, gender, medical issues)

Detailed description

This study is an exploratory descriptive survey study.

The study protocol will be largely replicated from the IOC consensus paper and the questionnaires based according to SMHAT 1 with an athlete-specific screening tool (APSQ) and further eleven subsequent disorder-specific screening tools:

Eleven disorder specific screening tools:

1. General Anxiety Disorder-7 (GAD-7): assesses the presence of symptoms of anxiety. 2. Patient Health Questionnaire-9 (PHQ-9): assesses the presence of symptoms of depression. 3. Athlete Sleep Screening Questionnaire (ASSQ): assesses the presence of sleep disturbance. 4. Alcohol Use Disorders Identification Test Consumption (AUDIT-C): assesses the presence of alcohol misuse. 5. Cutting Down, Annoyance by Criticism, Guilty Feeling, and Eye-openers Adapted to Include Drugs (CAGE-AID): assesses the presence of substance misuse, being slightly adapted for the SMHAT (no focus on alcohol use as already explored with the AUDIT-C; additional question to explore which substance was used). 6. Brief Eating Disorder in Athletes Questionnaire (BEDA-Q): assesses the presence of disordered eating. 7. ADHD 8. Bipolar disorder 9. PTSD 10. Gambling 11. Psychosis

Additionally questions to assess exercise addiction will be used as it has been shown that exercise addiction may be particularly prevalent in endurance athletes.

Further questions about age, gender, country of origin, training data, past medical history and medication will be asked as well as a few specific questions about there thoughts on mental health issues as per IOC consensus paper

Interventions

  • Behavioral mental health issues
    survey on mental health issues in endurance athletes

Primary outcome measures

  • Number of participants with mental health issues [Time frame: March-September 2023]
Secondary outcome measures (1)
  • Number of participants with risk factors associated with mental health issues [Time frame: March-September 2023]

Eligibility criteria

Inclusion criteria

  • endurance athletes (marathon runners, ultramarathon runners and triathletes)
  • over the age of 16
  • all genders
  • recreational athletes (non- elite)
  • elite athletes (professional, international, college level)

Exclusion criteria

  • athletes that that are not competing or have not competed in an official endurance race
  • athletes that are younger than 16 years of age.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

France · 1 center
  • Ultra Sports Science Foundation — Pierre-Bénite

Identifiers

NCT: NCT05768841 · VS1

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗